Taylor Hoffman Wealth Management’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
Sell
-1,000
Closed -$77K 206
2020
Q2
$77K Buy
+1,000
New +$76.6K 0.05% 168
2020
Q1
Sell
-1,300
Closed -$84K 208
2019
Q4
$84K Hold
1,300
0.05% 178
2019
Q3
$82K Hold
1,300
0.06% 173
2019
Q2
$88K Hold
1,300
0.07% 157
2019
Q1
$85K Hold
1,300
0.06% 155
2018
Q4
$81K Sell
1,300
-5,255
-80% -$367K 0.07% 142
2018
Q3
$506K Hold
6,555
0.4% 67
2018
Q2
$464K Sell
6,555
-36
-0.5% -$2.54K 0.4% 67
2018
Q1
$497K Buy
6,591
+87
+1% +$6.92K 0.45% 60
2017
Q4
$466K Buy
+6,504
New +$494K 0.45% 64

Other funds holding GILD

Taylor Hoffman Wealth Management's GILD Position: Q3 2020 in Review

Taylor Hoffman Wealth Management sold out of Gilead Sciences (GILD) in Q3 2020, closing a stake of 1,000 shares — an estimated $77K sold.

Taylor Hoffman Wealth Management first reported a position in GILD in Q4 2017 and held it in 10 quarters. The position peaked at $506K in Q3 2018. 1,538 funds tracked by Wall St. Rank hold GILD as of Q3 2020.

  • Taylor Hoffman Wealth Management reported no remaining Gilead Sciences position as of Q3 2020 after selling out during the quarter.
  • Taylor Hoffman Wealth Management sold 1,000 Gilead Sciences shares in Q3 2020, an estimated $77K.
  • Taylor Hoffman Wealth Management first reported a position in Gilead Sciences in Q4 2017 and held it in 10 quarters.
  • Taylor Hoffman Wealth Management's Gilead Sciences position peaked at $506K in Q3 2018.
  • 1,538 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2020.

Based on Taylor Hoffman Wealth Management's 13F filing for Q3 2020, filed 29 Oct 2020.